Original Research

Cost-Effectiveness Analysis of Maintenance Olaparib in Patients with Metastatic Pancreatic Cancer and a Germline BRCA1/2 Mutation Based on the POLO Trial

Zhan M, Zheng H, Yang Y, He Z, Xu T, Li Q

Cancer Management and Research 2020, 12:12919-12926

Published Date: 16 December 2020